These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Alobaidi HM; Coles GA; Davies M; Lloyd D Nephrol Dial Transplant; 1986; 1(1):16-21. PubMed ID: 3110659 [TBL] [Abstract][Full Text] [Related]
24. [Functional activity of monocytes-macrophages and neutrophils of blood and peritoneal effluent in patients with end-stage kidney failure maintained by permanent peritoneal dialysis at an outpatient setting]. Romanova LA; Lugovskaia SA; Shutov EV; Levina AA; Frolova OE; Korovina VI Klin Lab Diagn; 2001 Mar; (3):44-7. PubMed ID: 12014080 [No Abstract] [Full Text] [Related]
25. Development of exudate-resident macrophages in vivo and in vitro. Beelen RH Haematol Blood Transfus; 1981; 27():89-100. PubMed ID: 7327437 [TBL] [Abstract][Full Text] [Related]
26. Effect of peritoneal dialysis fluid measured in vivo in a rat-model of continuous peritoneal dialysis. Hekking LH; Aalders MC; Van Gelderop E; Zweers MM; Struijk DG; Havenith CE; Beelen RH Adv Perit Dial; 1998; 14():14-8. PubMed ID: 10649683 [TBL] [Abstract][Full Text] [Related]
27. HLA-DR expression on human peritoneal macrophages in vivo and in vitro. Bos HJ; Keizer GD; vd Muijsenberg AJ; Beelen RH Cell Biol Int Rep; 1990 Jun; 14(6):499-508. PubMed ID: 2196125 [TBL] [Abstract][Full Text] [Related]
28. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Lin CY; Ku WL; Huang TP Am J Nephrol; 1990; 10(5):368-73. PubMed ID: 1964368 [TBL] [Abstract][Full Text] [Related]
29. Erythropoietin and uremic toxicity during continuous ambulatory peritoneal dialysis. Wideröe TE; Sanengen T; Halvorsen S Kidney Int Suppl; 1983 Dec; 16():S208-17. PubMed ID: 6588251 [TBL] [Abstract][Full Text] [Related]
30. The development of the resident pattern of endogenous peroxidatic activity in mouse peritoneal macrophages coincides with the expression of the differentiation antigen F4/80. A combined method for immunoperoxidase labeling and endogenous peroxidase cytochemistry. Hoefsmit EC; Schadee-Eestermans IL; Beelen RH J Histochem Cytochem; 1986 May; 34(5):633-40. PubMed ID: 3517147 [TBL] [Abstract][Full Text] [Related]
31. The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. Mackenzie RK; Coles GA; Williams JD J Infect Dis; 1991 Apr; 163(4):837-42. PubMed ID: 1849163 [TBL] [Abstract][Full Text] [Related]
32. Suppressor resident peritoneal macrophages and peritonitis incidence in continuous ambulatory peritoneal dialysis. Lamperi S; Carozzi S Nephron; 1986; 44(3):219-25. PubMed ID: 2946966 [TBL] [Abstract][Full Text] [Related]
33. Changes in the phagocytic cells in children treated with continuous ambulatory peritoneal dialysis. Wasik M; Blaim M; Kolewska D; Janota-Krawczyk E; Tomaszewska-Pańczyk M; Sieniawska M Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):189-94. PubMed ID: 9597086 [TBL] [Abstract][Full Text] [Related]
34. Effect of CAPD dialysate on the release of eicosanoids and cytokines from human peritoneal macrophages. Steinhauer HB; Brugger U; Atmanspacher R; Lubrich-Birkner I; Schollmeyer P Adv Perit Dial; 1992; 8():47-52. PubMed ID: 1361851 [TBL] [Abstract][Full Text] [Related]
35. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. de Fijter CW; Verbrugh HA; Peters ED; Oe PL; van der Meulen J; Verhoef J; Donker AJ Clin Nephrol; 1993 Feb; 39(2):75-80. PubMed ID: 8448921 [TBL] [Abstract][Full Text] [Related]
36. Human peritoneal macrophages: clinical models of inflammation and potential targets of antiinflammatory drugs. Wilson JH; Bonta IL Agents Actions; 1986 Jan; 17(3-4):338-41. PubMed ID: 3083658 [TBL] [Abstract][Full Text] [Related]
37. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Sach M; Loetscher P; Burger JA; Knopf HP; Schollmeyer P; Dobos GJ Adv Perit Dial; 1995; 11():19-23. PubMed ID: 8534702 [TBL] [Abstract][Full Text] [Related]
38. Treatment of peritonitis in patients undergoing continuous ambulatory peritoneal dialysis. Horton MW; Deeter RG; Sherman RA Clin Pharm; 1990 Feb; 9(2):102-18. PubMed ID: 2407420 [TBL] [Abstract][Full Text] [Related]
39. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis? de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393 [TBL] [Abstract][Full Text] [Related]
40. Quantitative study on the production and kinetics of mononuclear phagocytes during an acute inflammatory reaction. Van Furth R; Diesselhoff-den Dulk MC; Mattie H J Exp Med; 1973 Dec; 138(6):1314-30. PubMed ID: 4762549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]